181 related articles for article (PubMed ID: 9686934)
1. Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated rats.
Salmi P; Malmgren K; Svensson TH; Ahlenius S
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):593-9. PubMed ID: 9686934
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride.
Wise RA; Carlezon WA
Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
Lublin H; Gerlach J; Peacock L
Psychopharmacology (Berl); 1993; 112(2-3):389-97. PubMed ID: 7871047
[TBL] [Abstract][Full Text] [Related]
4. Time sampling observation procedure for studying drug effects: interaction between d-amphetamine and selective dopamine receptor antagonists in the rat.
Petry N; Furmidge L; Tong ZY; Martin C; Clark D
Pharmacol Biochem Behav; 1993 Jan; 44(1):167-80. PubMed ID: 8430120
[TBL] [Abstract][Full Text] [Related]
5. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
Lublin H; Gerlach J; Mørkeberg F
Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
[TBL] [Abstract][Full Text] [Related]
7. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
Isacson R; Kull B; Wahlestedt C; Salmi P
Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
[TBL] [Abstract][Full Text] [Related]
8. Intraaccumbens raclopride attenuates amphetamine-induced locomotion, but fails to prevent the response-reinstating properties of food reinforcement.
Chausmer A; Ettenberg A
Pharmacol Biochem Behav; 1999 Feb; 62(2):299-305. PubMed ID: 9972697
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
Protais P; Chagraoui A; Arbaoui J; Mocaër E
Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
[TBL] [Abstract][Full Text] [Related]
10. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats.
Ouagazzal A; Nieoullon A; Amalric M
Psychopharmacology (Berl); 1993; 111(4):427-34. PubMed ID: 7870984
[TBL] [Abstract][Full Text] [Related]
11. Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion.
Neisewander JL; Fuchs RA; O'Dell LE; Khroyan TV
Synapse; 1998 Oct; 30(2):194-204. PubMed ID: 9723789
[TBL] [Abstract][Full Text] [Related]
12. Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats.
Wilkerson A; Levin ED
Neuroscience; 1999 Mar; 89(3):743-9. PubMed ID: 10199609
[TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of dopaminergic blockade on MDMA and d-amphetamine conditioned taste aversions.
Lin HQ; McGregor IS; Atrens DM; Christie MJ; Jackson DM
Pharmacol Biochem Behav; 1994 Feb; 47(2):369-74. PubMed ID: 7908448
[TBL] [Abstract][Full Text] [Related]
14. Self-administration of the D1 agonist SKF 82958 is mediated by D1, not D2, receptors.
Self DW; Belluzzi JD; Kossuth S; Stein L
Psychopharmacology (Berl); 1996 Feb; 123(4):303-6. PubMed ID: 8867867
[TBL] [Abstract][Full Text] [Related]
15. Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.
Ferger B; Kropf W; Kuschinsky K
Psychopharmacology (Berl); 1994 Mar; 114(2):297-308. PubMed ID: 7838923
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the selective D2-antagonist raclopride in the nucleus accumbens of the rat on spontaneous and d-amphetamine-induced activity.
van den Boss R; Cools AR; Ogren SO
Psychopharmacology (Berl); 1988; 95(4):447-51. PubMed ID: 2975012
[TBL] [Abstract][Full Text] [Related]
17. Indirect dopamine agonists effects on despair test: dissociation from hyperactivity.
Vaugeois JM; Pouhé D; Zuccaro F; Costentin J
Pharmacol Biochem Behav; 1996 May; 54(1):235-9. PubMed ID: 8728563
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
[TBL] [Abstract][Full Text] [Related]
19. Chronic haloperidol alters dopamine receptors: effects of cocaine exposure during the preweaning period.
Shi X; Yin R; Dow-Edwards D
Eur J Pharmacol; 1999 Apr; 370(3):241-9. PubMed ID: 10334498
[TBL] [Abstract][Full Text] [Related]
20. The effects of haloperidol and raclopride in the paw test are influenced similarly by SCH 39166.
Prinssen EP; Ellenbroek BA; Stamatovic B; Cools AR
Eur J Pharmacol; 1993 Feb; 231(2):275-80. PubMed ID: 8095900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
